References
Noh SH, Park SR, Yang H-K, Chung HC, Chung I-J, Kim S-W, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15:1389–96.
Coimbra FJF, de Jesus VHF, Ribeiro HSC, et al. Impact of ypT, ypN, and adjuvant therapy on survival in gastric cancer patients treated with perioperative chemotherapy and radical surgery. Ann Surg Oncol. 2019;26:3618–26.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
ASO Author Reflections offer a brief invited commentary on the article, “Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery”. Ann Surg Oncol. 2019;26:3618–3626.
Rights and permissions
About this article
Cite this article
Coimbra, F.J.F., da Costa, W.L. ASO Author Reflections: High-Quality Perioperative and Surgical Therapy: The Impact of Tumor Response in Survival. Ann Surg Oncol 27 (Suppl 3), 729–730 (2020). https://doi.org/10.1245/s10434-019-07959-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-019-07959-8